Participants will each receive a single intravenous infusion of AFTX-201 at doses determined from preclinical studies.

The UPBEAT (c) clinical trial is a multicenter, open-label Phase 1/2 clinical trial designed to evaluate the safety, tolerability, pharmacodynamics, and preliminary efficacy of AFTX-201 in adults with ...

Waltham, Massachusetts Saturday, February 7, 2026, 18:00 Hrs [IST] ...

Mr. Willard has a 30+ year track record of leadership across public and private sectors as CEO of multiple biotechnology and pharmaceutical ...

One of the most widely used safety requirements in working environments, laboratories, workshops, and factories is eye ...

We were honored to receive the 2025 Clinical Trials Arena R&D Excellence Award in the Precision Endocrine Therapy category, reflecting growing awareness of the utility of (Z)-endoxifen across oncology ...

Discover the top 4 undervalued Health Care Equipment & Supplies stocks for Wednesday, February 11 based on AAII’s Stock ...

India: A new review published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews suggests that simple, ...

Retinoblastoma is the most common eye cancer in children. Learn early warning signs, causes, diagnosis and why timely treatment can save a child’s vision and life.

Irritated by predatory journals and fake conferences, one mathematics researcher decided to submit an obviously AI-generated ...

Discover expert dog health guides covering nutrition, exercise, common conditions, preventive care, and mental wellness.

Discover how raw eye-tracking data can be transformed into effective cognitive load indicators, providing insights into how ...